Word: estrogenic
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Scientists like vom Saal argue that BPA and phthalates are different from other environmental toxins like lead and mercury in that these plastic ingredients are endocrine disrupters, which mimic hormones. Estrogen and other hormones in relatively tiny amounts can cause vast changes, so some researchers worry that BPA and phthalates could do the same, especially in young children. Animal studies on BPA found that low-dose exposure, particularly during pregnancy, may be associated with a variety of ills, including cancer and reproductive problems. Some human studies on phthalates linked exposure to declining sperm quality in adult males, while other work...
...water bottles merit scrutiny as well. Like many rock climbers, Scott Belcher used to carry a Nalgene water bottle made of polycarbonate, a sturdy, clear plastic. As an associate pharmacology professor at the University of Cincinnati, he knew that polycarbonates contain bisphenol A (BPA), a synthetic hormone that mimics estrogen. What he didn't know was if or how much BPA wound up in his water. In experiments, he learned that trace amounts of BPA do seep into room-temperature water. But he was startled to find that when the containers were filled with boiling water--a common practice...
...book, The Doctors' Case Against the Pill, is widely credited with sparking the women's-health movement of the '70s. Pioneering author-activist Barbara Seaman began to research the high-estrogen birth-control pill after readers of her magazine column complained of painful symptoms. Seaman's book, which exposed side effects, including stroke, heart attack and depression, led to highly publicized Senate hearings and ultimately to mandated warning labels and patient-information inserts. She was 72 and had lung cancer...
...Manson also notes that at the time the study was being conducted, between 1993 and 1998, the estrogen and progestin preparations were not available in the lower doses that are used today, and that most women had been taking the hormones for longer than the one to two years that current guidelines recommend. (Researchers are planning to study the long-term risk-benefit profile of lower dose formulations and shorter exposure periods...
...viable option for short-term treatment of menopausal symptoms. When used for the short-term treatment of distressing symptoms, it's likely that the benefits outweigh the risks." As confusing as they seem, taken together, every analysis from the WHI actually does paint a clearer picture of how estrogen and progestin can affect a woman's body during and after menopause, and doctors are learning more about the safest way to provide women with the advantages of these hormones in relieving menopausal symptoms. It's just that the story has many chapters yet to come...